Nichols, David E.

Psychedelics

Nichols, D. E. (2016) · Pharmacological Reviews

Psychedelics and Drug StudiesNeurotransmitter Receptor Influence on Behavior

Cited by 1,762

Hallucinogens

Nichols, D. E. (2004) · Pharmacology & Therapeutics

Psychedelics and Drug StudiesHallucinations in medical conditions

Cited by 1,211

Serotonin Receptors

Nichols, D. E., & Nichols, C. D. (2008) · Chemical Reviews

Receptor Mechanisms and SignalingNeurotransmitter Receptor Influence on Behavior

Cited by 895

Neural correlates of the LSD experience revealed by multimodal neuroimaging

Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., Tagliazucchi, E., Schenberg, E. E., Nest, T., Orban, C., et al. (2016) · Proceedings of the National Academy of Sciences

Psychedelics and Drug StudiesHallucinations in medical conditions

Cited by 859

Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor

Kim, K., Che, T., Panova, O., DiBerto, J. F., Lyu, J., Krumm, B. E., Wacker, D., Robertson, M. J., Seven, A. B., Nichols, D. E., et al. (2020) · Cell

Receptor Mechanisms and SignalingPsychedelics and Drug Studies

Cited by 481

Psychedelic Drugs in Biomedicine

Kyzar, E. J., Nichols, C. D., Gainetdinov, R. R., Nichols, D. E., & Kalueff, A. V. (2017) · Trends in Pharmacological Sciences

Psychedelics and Drug StudiesNeurotransmitter Receptor Influence on Behavior

Cited by 155

A complex signaling cascade links the serotonin2A receptor to phospholipase A2 activation: the involvement of MAP kinases

Kurrasch‐Orbaugh, D. M., Parrish, J. C., Watts, V. J., & Nichols, D. E. (2003) · Journal of Neurochemistry

Receptor Mechanisms and SignalingProtein Kinase Regulation and GTPase Signaling

Cited by 138

Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines

Blair, J. B., Kurrasch-Orbaugh, D., Marona-Lewicka, D., Cumbay, M. G., Watts, V. J., Barker, E. L., & Nichols, D. E. (2000) · Journal of Medicinal Chemistry

Psychedelics and Drug StudiesForensic Toxicology and Drug Analysis

Cited by 131

Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase

Mottola, D. M., Kilts, J. D., Lewis, M. M., Connery, H. S., Walker, Q. D., Jones, S. R., Booth, R. G., Hyslop, D. K., Piercey, M., Wightman, R. M., et al. (2002) · The Journal of Pharmacology and Experimental Therapeutics

Receptor Mechanisms and SignalingNeurotransmitter Receptor Influence on Behavior

Cited by 123

N,N -dimethyltryptamine and the pineal gland: Separating fact from myth

Nichols, D. E. (2018) · Journal of Psychopharmacology

Psychedelics and Drug StudiesParanormal Experiences and Beliefs

Cited by 69

Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia

Martin, D. A., Marona-Lewicka, D., Nichols, D. E., & Nichols, C. D. (2014) · Neuropharmacology

Psychedelics and Drug StudiesSchizophrenia research and treatment

Cited by 67

Behavioral effects of α,α,β,β-tetradeutero-5-MeO-DMT in rats: comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitor

Halberstadt, A. L., Nichols, D. E., & Geyer, M. A. (2012) · Psychopharmacology

Psychedelics and Drug StudiesNeurotransmitter Receptor Influence on Behavior

Cited by 57

Differential phospholipase C activation by phenylalkylamine serotonin 5‐HT2Areceptor agonists

Parrish, J. C., Braden, M. R., Gundy, E., & Nichols, D. E. (2005) · Journal of Neurochemistry

Receptor Mechanisms and SignalingNeurotransmitter Receptor Influence on Behavior

Cited by 41